First-in-Human Clinical Safety Trial is Successfully Launched using ReSolv™, the Unique Polymer-Based Flow-Diverting Stent Designed to Treat Brain Aneurysms Company Advisory Board Expands to Include Respected Medical Key Opinion Leader and Medtech Entrepreneur CALGARY, AB, June 1, 2023 /PRNewswire/ – Fluid Biomed Inc., a medical device company developing ReSolv™, the world’s first hybrid […]
Other News
Esperion Announces Submission of Supplemental New Drug Applications to U.S. FDA for NEXLETOL® (bempedoic acid) Tablet and NEXLIZET® (bempedoic acid and ezetimibe) Tablet
– Submitted four efficacy supplements seeking inclusion of CV risk reduction and expansion of LDL-C lowering – – Anticipated approvals in U.S. in the first half of 2024 – ANN ARBOR, Mich., June 01, 2023 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced that it has submitted Supplemental New Drug Applications (sNDA) to […]
Aerami Therapeutics Appoints Joshua Ziel as COO and Interim CEO and Expands Management Team as Lead Asset AER-901 (inhaled imatinib) Advances Toward Phase 2 in Pulmonary Hypertension
Joshua Ziel, PhD, appointed as Chief Operating Officer and interim Chief Executive Officer Gary Burgess, MD, appointed as Chief Medical Officer Sarah Fritchley, PhD, appointed as Senior Vice President, Clinical Development and Operations DURHAM, N.C., June 01, 2023 (GLOBE NEWSWIRE) — Aerami Therapeutics (“Aerami”), a clinical stage biopharmaceutical company dedicated […]
Lexicon Announces Pricing of $125 Million Public Offering and Concurrent Private Placement
THE WOODLANDS, Texas, June 01, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) (“Lexicon”) today announced the pricing of its previously announced underwritten public offering of 23,924,705 shares of its common stock, par value $0.001. The shares of common stock being offered pursuant to the public offering are being […]
Lundquist Institute Investigators Co-Author Paper in JAMA on Coronary Heart Disease (CHD) Risk Prediction
Drs. Jerome Rotter & Matt Budoff Study Shows that in Middle-aged to Older Adults the Coronary Artery Calcium Score Improved CHD Risk Discrimination Los Angeles, June 01, 2023 (GLOBE NEWSWIRE) — The Lundquist Institute (TLI) announced today that Jerome Rotter, MD, and Matthew Budoff, MD, two of TLI’s investigators, are […]
Cleerly Partners with ProScan Imaging to Transform the Standard of Care for Heart Disease Prevention
ProScan’s imaging centers in two major regions will now leverage Cleerly’s AI-enabled approach to develop personalized heart care diagnoses and treatment plans DENVER – May 31, 2023 — Cleerly, the company creating a new standard of care for heart disease, announced today a partnership with ProScan Imaging to offer more personalized […]
Kardium Announces First US Procedures in PULSAR Study of Globe® Pulsed Field System
VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium Inc., a private medical device company that has developed the Globe System for the treatment of atrial fibrillation (AF) using pulsed field ablation (PFA), announced today that the first US patients have been successfully treated in the PULSAR clinical study. The PULSAR study will enroll over 400 patients […]
Vivalink Releases 14-Day Live Stream Wearable ECG Patch for Ambulatory Cardiac Monitoring
Rechargeable multi-parameter wearable patch enables continuous and real time monitoring of remote patients CAMPBELL, Calif. , May 31, 2023 /PRNewswire/ — Vivalink, a leading provider of digital healthcare solutions, is announcing the newest version of its multi-parameter wearable electrocardiogram (ECG) patch with continuous 14-day live stream capabilities. With Vivalink’s new patch, extended duration remote […]
Valve Medical Announces Successful First-in-Human Implantation of Ultra-low Profile TAVR Valve in Israel
TEL AVIV, Israel, May 31, 2023 /PRNewswire/ — Valve Medical, a wholly owned subsidiary of Medinol Ltd. is pleased to announce today the successful First-in-Human (FIH) implantation of their advanced Transcatheter Aortic Valve Replacement (TAVR) system in Israel, introducing a revolutionary advancement in Structural Heart procedures with the world’s first modular valve. The […]
Boston Scientific Announces Conversion Date of Series A Mandatory Convertible Preferred Stock
MARLBOROUGH, Mass., May 30, 2023 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) announced today that its Series A 5.50% Mandatory Convertible Preferred Stock (the preferred stock) will automatically convert into shares of the company’s common stock on June 1, 2023. As previously disclosed, holders of record at the close of business on May 15, 2023 will […]



